Multi-organ Transit Time Acquisition Using Contrast Ultrasound
- Registration Number
- NCT05135169
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
- at least 18 years old
- able to give informed consent
Exclusion Criteria
- Known allergic reaction to Definity ultrasound contrast
- Pregnancy/Nursing - as assessed/disclosed by the participant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Contrast administration Definity Suspension for Injection -
- Primary Outcome Measures
Name Time Method transit time during procedure time it takes for contrast to traverse an organ
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does Definity contrast use to measure organ transit times in healthy volunteers?
How does Definity Suspension for Injection compare to standard ultrasound contrast agents in multi-organ imaging?
Are there specific biomarkers that correlate with enhanced vascular visualization using Definity in observational studies?
What adverse events are associated with contrast-enhanced ultrasound using Definity in healthy populations?
What alternative contrast agents or imaging modalities are being explored for multi-organ transit time assessment in clinical research?
Trial Locations
- Locations (1)
VUMC
🇺🇸Nashville, Tennessee, United States
VUMC🇺🇸Nashville, Tennessee, United States